© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Substance Name: Dactinomycin (also known as Actinomycin D)
Common Applications: Often used as a chemotherapy agent for a variety of cancers like Wilms tumor, rhabdomyosarcoma, and testicular cancer. Those who administer or work around it typically find themselves in oncology wards, pharmacy compounding rooms, or research labs.
Physical Description: Dactinomycin typically presents as a bright red to orange powder, requiring care in preparation, as it easily becomes airborne.
Hazards to Humans: Exposure causes severe irritation of skin, eyes, and respiratory tract. Inhalation or direct contact proves extremely harmful. Dactinomycin comes with a reputation as a confirmed carcinogen and a genotoxic compound. Even small quantities can trigger toxic reactions, and those involved in its handling need to stay vigilant to avoid accidental contact.
Acute Effects: Nausea, vomiting, tissue necrosis if extravasation occurs, and respiratory distress.
Chronic Effects: Known to cause organ toxicity and secondary cancers in long-term settings. People working with dactinomycin over extended periods face increased health risks compared to short-term users.
Active Ingredient: Dactinomycin
Chemical Formula: C62H86N12O16
Concentration: Drug preparations use various strengths; the workspace often deals with concentrated vials and diluted solutions.
Inhalation: Move to fresh air immediately. Medical evaluation is necessary, as respiratory tract irritation can escalate quickly.
Skin Contact: Wash area thoroughly using soap and water. Contaminated clothing should be removed and handled separately to avoid cross-contamination.
Eye Contact: Flush eyes with copious amounts of water for several minutes. Avoid rubbing.
Ingestion: Seek expert medical attention; do not induce vomiting, and keep patient under surveillance due to potential systemic toxicity.
General Tip: Prompt action after exposure means better outcomes, reducing the odds of complications.
Suitable Extinguishing Media: Water spray, carbon dioxide, and dry chemical for small fires.
Hazardous Combustion Products: Fumes may contain carbon oxides, nitrogen oxides, and toxic organic compounds.
Protection for Firefighters: Full protective gear along with self-contained breathing apparatus. Even residual powder in a fire can pose a risk.
Personal Precautions: Trained personnel should wear gloves, gowns, eye protection, and respiratory equipment.
Environmental Precautions: Dactinomycin contamination in water supplies can jeopardize aquatic ecosystems; restrict spill from entering drains or soil.
Cleanup Methods: Use absorbent materials and dispose of in chemically hazardous waste. Wet cleaning prevents airborne spread.
Handling: Those compounding or administering dactinomycin should work in negative pressure rooms, use biosafety cabinets, and stay vigilant about accidental splashes.
Storage: Refrigerate powders and solutions; store away from light, preferably in clearly marked, secure cabinets. Limit access to those trained in hazardous drug handling.
Waste Handling: Treat any materials, vials, or syringes as hazardous medical waste, as residues can linger and pose long-term exposure risks to cleaning staff.
Engineering Controls: Certified chemical fume hoods or Class II biosafety cabinets act as the primary layer of defense.
Personal Protective Equipment: Gloves resistant to cytotoxic agents, impermeable gowns, goggles, and certified masks. Double-gloving and changing gloves regularly matters more than most realize.
Occupational Limits: Dactinomycin lacks broadly established occupational exposure limits, but extreme caution and routine air monitoring are widely practiced in healthcare settings.
Physical State: Solid, lyophilized powder.
Color: Vivid red to orange.
Solubility: Readily dissolves in water or dilute acids.
Odor: Nearly odorless though strong enough in some settings to cause nasal irritation.
Melting Point: Data limited, as decomposition occurs before melting becomes relevant in everyday work.
Stability: Dactinomycin keeps stable under recommended refrigeration and light protection. Improper storage leads to degradation products with unknown risks.
Reactivity: Incompatible with strong oxidizers and bases. Mishandling these combinations can trigger hazardous conditions and waste precious compound.
Routes of Exposure: Inhalation, dermal contact, ingestion, and accidental injection. Laboratory settings and hospitals represent typical risk areas.
Acute Toxicity: Symptoms show up quickly and include tissue necrosis at contact sites, nausea, vomiting, and sometimes acute organ failure.
Carcinogenicity and Mutagenicity: Confirmed by multiple studies, dactinomycin is both genotoxic and carcinogenic, with risks heightened for those who experience repeated low-dose exposure over long stretches.
Environmental Risks: Dactinomycin persists in water and soil. It is toxic to aquatic organisms and can disrupt local ecological balance. Hospitals and labs need protocols to monitor effluent and prevent accidental release, as even trace amounts may affect nearby waterways for years.
Waste Management: All containers, expired stock, and contaminated materials go into specialized hazardous drug waste streams. Incineration at approved facilities is standard practice; landfilling increases environmental risk.
Preventing Contamination: Routine training for staff, segregated bins, and clear labeling form the backbone of a responsible disposal strategy. Waste handlers deserve equal attention, as repeated mishandling threatens both individual health and community safety.
Shipping Class: Dactinomycin ships as a hazardous material. Carriers demand full documentation and secure packaging. Packages must prevent breakage or accidental release during transport, especially as leaks can put everyone along the supply chain at risk.
Labeling: Clear cytotoxic and poison markings reduce the odds of accidental exposure. Institutions moving dactinomycin between locations rely heavily on traceable, auditable shipping protocols.
Workplace Regulations: Many countries classify dactinomycin as a hazardous drug, and require employers to develop risk assessments, train staff, and offer medical surveillance to handlers.
Environmental Rules: Regulations often set limits on discharge and require waste tracking to ensure all hazardous drugs are destroyed, not dumped.
Occupational Safety: Strong regulatory frameworks back up employment protections, making sure those handling dactinomycin always have access to the latest safety gear and know-how.
